Cognitive functioning in breast cancer survivors: A controlled comparison

Cancer

Volumn 115, Issue 8, 2009, Pages 1776-1783

  Jim, Heather S L ^a   Donovan, Kristine A ^a   Small, Brent J ^a   Andrykowski, Michael A ^b   Munster, Pamela N ^c   Jacobsen, Paul B ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant chemotherapy; Adjuvant radiotherapy; Breast neoplasms; Cognition; Neuropsychologic tests

Indexed keywords

ANASTROZOLE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MEGESTROL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TOREMIFENE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; ATTENTION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HORMONAL THERAPY; HUMAN; INTELLECT; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEMORY; MONOTHERAPY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUALITY OF LIFE; TASK PERFORMANCE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; SURVIVORS;

EID: 65249144566     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24192     Document Type: Article

References (35)

1. Gross J. Chemotherapy fog is no longer ignored as illusion. New York Times. April 29, 2007. Available at: http://nytimes.com/2007/04/29/health/ 29chemo.html Accessed January 28, 2009.
2. American Cancer Society. 'Chemo brain' not all in your head. Available at: http://www.cancer.org/docroot/NWS/content/NWS-1-1x-Chemo-Brain-Not-All-in- Your-Head. asp Accessed November 15, 2007.
3. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer 2005;104(11 suppl):2565-2576.
4. Mehnert A, Scherwath A, Schirmer L, et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns. 2007;66:108-118.
5. Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999;85:640-650.
6. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational longitudinal study. Breast 2005;14:142-150.
7. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2000;18:2695-2701.
8. Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapyfor breastcancer. J Clin Oncol. 2003; 21:4175-4183.
9. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc. 2003;9:967-982.
10. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 1995;4:61-66.
11. Fan HG, Houede-Tchen N, Yi QL, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005;23:8025-8032.
12. Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant- treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007;103:303-311.
13. Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002;13:1387-1397.
14. Jenkins V, Shilling V, Deutsch G, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 2006;94:828-834.
15. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005;104:2499-2507.
16. van Dam FSAM, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 1998;90:210-218.
17. Andrykowski MA, Schmitt FA, Gregg ME, Brady MI, Lamb DG, Henslee-Downey J. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer 1992;70:2288-2297.
18. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, Berks, UK: NFER-Nelson; 1982.
19. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Adult Version. San Antonio TX: Psychological Corporation; 1987.
20. Weschler D. Weschler Memory Scale-III Manual. San Antonio TX: Psychological Corporation; 1997.
21. Weschler D. WAIS-III Administration and Scoring Manual. San Antonio TX: Psychological Corporation; 1997.
22. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsy- chological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993.
23. Ruff RM, Allen CC. Ruff 2 & 7 Selective Attention Test: Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc.; 1995.
24. Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City, IA: AJA Associates; 1989.
25. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol. 1994;16: 93-104.
26. Hann DM, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998;7:301-310.
27. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16: 1689-1696.
28. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
29. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999;46:437-443.
30. Beeber LS, Shea J, McCorkle R. The Center for Epidemiological Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol. 1998;16:1-20.
31. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 2004;100: 2292-2299.
32. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.
33. Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 2004;13:61-66.
34. Shilling V, Jenkins V, Fallowfield L, Howell T. The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol. 2003;86:405-412.
35. Phillips K, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst. 2003;95:190-197.